AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.47 |
Market Cap | 10.13M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.15 |
PE Ratio (ttm) | -0.5 |
Forward PE | n/a |
Analyst | Buy |
Ask | 0.62 |
Volume | 55,221 |
Avg. Volume (20D) | 103,768 |
Open | 0.62 |
Previous Close | 0.62 |
Day's Range | 0.57 - 0.62 |
52-Week Range | 0.57 - 5.65 |
Beta | undefined |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service fo...
Analyst Forecast
According to 2 analyst ratings, the average rating for AWH stock is "Buy." The 12-month stock price forecast is $4.4, which is an increase of 661.51% from the latest price.
Next Earnings Release
Analysts project revenue of $2.40M, reflecting a 12.68% YoY growth and earnings per share of -0.22, making a -26.67% decrease YoY.
2 months ago · seekingalpha.com
Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call TranscriptAspira Women's Health Inc. (NASDAQ:AWH ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Nicole Sandford - Chief Executive Officer & Director Sandy Milligan - Presid...